Compound Detail
CHEMBL5172646
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5172646 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AZZJYDCCIOUUEY-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
7
Publications
0
Known Names
Molecular Properties
316.4
MW (Da)
2.79
ALogP
6
HBA
0
HBD
52.2
PSA (Ų)
0.64
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 4.64
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | EC50 | 4.64 | 4.64 | 23000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | EC50 | = | 23000.0 | nM | 4.64 | Antiviral activity against Human rhinovirus A71 infected in human H1-HeLa cells ... | 35292344 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35292344 | 10.1016/j.bmcl.2022.128673 | rhinovirus B14 | 1 |
| 35292344 | 10.1016/j.bmcl.2022.128673 | rhinovirus A21 | 1 |
| 35292344 | 10.1016/j.bmcl.2022.128673 | Unchecked | 1 |
| 35292344 | 10.1016/j.bmcl.2022.128673 | H1-HeLa | 1 |
| 35292344 | 10.1016/j.bmcl.2022.128673 | ADMET | 1 |
| 35292344 | 10.1016/j.bmcl.2022.128673 | Coxsackievirus B1 | 1 |
| 35292344 | 10.1016/j.bmcl.2022.128673 | Poliovirus 3 | 1 |
Data from ChEMBL 36 via Core Engine